|

Alzheimer's Disease Clinical Trials in Raleigh, NC

15 recruiting studies within 50 miles

Phase
Trial Phase Dist.
Late Onset Alzheimer's Disease—<1 mi
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's DiseasePhase 2<1 mi
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's DementiaPhase 2<1 mi
A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)Phase 121 mi
Olfactory BiopsiesN/A21 mi
A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's DiseasePhase 121 mi
Preventing Alzheimer's With Cognitive TrainingPhase 321 mi
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR VariantPhase 321 mi
Effect of Acetylcholinesterase Inhibitors on Bone MetabolismPhase 221 mi
Retinal Imaging in Neurodegenerative Disease—21 mi
ADRC Clinical Cohort (Alzheimer's Disease)—21 mi
Physical Activity and Community EmPOWERment ProjectN/A25 mi
Improving PCP Advance Care Planning for People With ADRDN/A25 mi
Connect-Home: Alzheimer's Disease and Related DementiasN/A25 mi
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's DiseasePhase 225 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.